633 Dual-targeting of 4–1BB and OX40 with an ADAPTIR™ bispecific antibody enhances anti-tumor responses to solid tumor

by Michelle Nelson, Robert Miller, Gabriele Blahnik-Fagan, Lauren Loh, Danielle Van Citters, Lynda Misher, Megan Sprague, Maria Dasovich, Irene Barber, Kathy Maggiora, Franz Gruswitz, Brian Woodruff, Kelsey Huntington, Aelish Guinn, Megan Aguilar, Mollie Daugherty, Elizabeth Haglin, Jane Gross, Peter Pavlik, Catherine McMahan, David Bienvenue, Gabriela Hernandez-Hoyos
Published 2020-11-01

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy

by Varun Vijay Prabhu, Sara Morrow, Abed Rahman Kawakibi, Lanlan Zhou, Marie Ralff, Jocelyn Ray, Aakash Jhaveri, Isacco Ferrarini, Young Lee, Cassandra Parker, Yiqun Zhang, Robyn Borsuk, Wen-I Chang, Joshua N. Honeyman, Fabio Tavora, Benedito Carneiro, Alexander Raufi, Kelsey Huntington, Lindsey Carlsen, Anna Louie, Howard Safran, Attila A. Seyhan, Rohinton S. Tarapore, Lee Schalop, Martin Stogniew, Joshua E. Allen, Wolfgang Oster, Wafik S. El-Deiry
Published 2020-12-01